Zimvie Inc. ( (ZIMV) ) has released its Q4 earnings. Here is a breakdown of the information Zimvie Inc. presented to its investors.
ZimVie Inc., a global leader in the dental market, specializes in developing and delivering products and solutions for dental tooth replacement and restoration procedures. Headquartered in Palm Beach Gardens, Florida, the company is known for its comprehensive portfolio of dental implants, biomaterials, and digital workflow solutions.
In its latest earnings report, ZimVie Inc. announced a net sales figure of $449.7 million for the fiscal year 2024, with a net loss of $33.8 million. Despite the overall net loss, the company reported an adjusted EBITDA of $60 million, reflecting a margin of 13.3%. The company has also successfully reduced its net debt by over $290 million, indicating a significant reshaping of its financial profile.
Key financial metrics from the report highlight a decrease in net sales by 1.6% compared to the previous year, while the net loss margin improved by 480 basis points. The adjusted net income for the year was $17 million, an increase of $11.1 million from the prior year. The fourth quarter of 2024 saw a net loss of $9.7 million, which was an improvement from the $22.2 million loss in the same quarter of the previous year.
Looking ahead, ZimVie Inc. projects net sales for 2025 to range between $445 million and $460 million, with an adjusted EBITDA expected to grow between 8% and 17%. The company remains optimistic about its position in the dental implant market, driven by its strategic initiatives and educational programs, and is poised to capitalize on market growth opportunities in 2025 and beyond.